Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Lz, Rassenti"'
Publikováno v:
Europe PubMed Central
We examined the lg heavy chain variable region genes (Ig V(H) genes) expressed in biopsy specimens of 10 patients with acquired immunodeficiency syndrome (AIDS)-associated lymphoma. Eight expressed Ig V(H) genes of the V(H)4 group, indicating a bias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8de3927162d224796876c6ea2a679c
https://pubmed.ncbi.nlm.nih.gov/8704181
https://pubmed.ncbi.nlm.nih.gov/8704181
Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features
Publikováno v:
Europe PubMed Central
Prior studies revealed that the leukemic B cells of patients with chronic lymphocytic leukemia (CLL) express a restricted Ig heavy chain variable region gene (VH gene) repertoire. However, this restriction needs to be re-evaluated in light of finding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b771957e5742bd97f43c3982e680958d
http://europepmc.org/abstract/med/8977195
http://europepmc.org/abstract/med/8977195
Autor:
Kashyap MK; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.; Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Panchgaon (Manesar), Gurugram (HR) 122413, India., Karathia H; Advanced Biomedical Computational Science and National Center for Advancing Translational Sciences, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.; Greenwood Genetic Center, Greenwood, SC, USA.; Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20742, USA., Kumar D; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Vera Alvarez R; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Forero-Forero JV; Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ 85054, USA., Moreno E; Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ 85054, USA., Lujan JV; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Amaya-Chanaga CI; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Vidal NM; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Yu Z; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA., Ghia EM; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA 92037, USA., Lengerke-Diaz PA; Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ 85054, USA., Achinko D; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Choi MY; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA 92037, USA., Rassenti LZ; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA 92037, USA., Mariño-Ramírez L; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Mount SM; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742, USA., Hannenhalli S; Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kipps TJ; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA 92037, USA., Castro JE; Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093-0820, USA.; Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ 85054, USA.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Apr 26; Vol. 35 (2), pp. 102202. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024).
Autor:
Shatsky RA; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Batra-Sharma H; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Helsten T; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Schwab RB; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Pittman EI; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Pu M; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Weihe E; Department of Radiology, University of California San Diego, La Jolla, San Diego, CA, USA., Ghia EM; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Rassenti LZ; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Molinolo A; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Cabrera B; University of California San Diego California Institute for Regenerative Medicine Alpha Clinic, La Jolla, San Diego, CA, USA., Breitmeyer JB; Oncternal Therapeutics, Inc., San Diego, CA, USA., Widhopf Ii GF; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Messer K; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, San Diego, CA, USA., Jamieson C; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.; University of California San Diego California Institute for Regenerative Medicine Alpha Clinic, La Jolla, San Diego, CA, USA.; Sanford Stem Cell Institute, University of California San Diego, La Jolla, San Diego, CA, USA., Kipps TJ; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Parker BA; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA. baparker@health.ucsd.edu.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA. baparker@health.ucsd.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Mar 13; Vol. 26 (1), pp. 46. Date of Electronic Publication: 2024 Mar 13.
Autor:
Shatsky RA; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Batra-Sharma H; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Helsten T; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Schwab RB; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA., Pittman EI; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Pu M; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Weihe E; Department of Radiology, University of California San Diego, La Jolla, San Diego, CA, USA., Ghia EM; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Rassenti LZ; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Molinolo A; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA., Cabrera B; University of California San Diego California Institute for Regenerative Medicine Alpha Clinic, La Jolla, San Diego, CA, USA., Breitmeyer JB; Oncternal Therapeutics, Inc., San Diego, CA, USA., Widhopf GF 2nd; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Messer K; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, San Diego, CA, USA., Jamieson C; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.; University of California San Diego California Institute for Regenerative Medicine Alpha Clinic, La Jolla, San Diego, CA, USA.; Sanford Stem Cell Institute, University of California San Diego, La Jolla, San Diego, CA, USA., Kipps TJ; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA.; Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA., Parker BA; Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA. baparker@health.ucsd.edu.; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA. baparker@health.ucsd.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Feb 26; Vol. 26 (1), pp. 32. Date of Electronic Publication: 2024 Feb 26.
Autor:
Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Guièze R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; CHU de Clermont-Ferrand, Clermont-Ferrand, France.; Université Clermont Auvergne, EA7453 CHELTER, Clermont-Ferrand, France., Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lemvigh C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, Nancy, France., Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France., Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Utro F; IBM Research, Yorktown Heights, New York, NY, USA., Levovitz C; IBM Research, Yorktown Heights, New York, NY, USA., Rhrissorrakrai K; IBM Research, Yorktown Heights, New York, NY, USA., Li L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Slowik K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jacobs R; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Lin Z; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Livitz D; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Taylor-Weiner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Persaud B; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Martinez A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Anandappa AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ma J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rassenti LZ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA., Kipps TJ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cymbalista F; Laboratoire d'hématologie, Hôpital Avicenne-AP-HP, INSERM U978- Université Sorbonne Paris Nord, Bobigny, France., Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Parida L; IBM Research, Yorktown Heights, New York, NY, USA., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, USA. cwu@partners.org.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. cwu@partners.org.
Publikováno v:
Nature medicine [Nat Med] 2023 Jan; Vol. 29 (1), pp. 158-169. Date of Electronic Publication: 2023 Jan 09.
Autor:
Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lin Z; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard University, Cambridge, MA, USA., Hahn CK; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Duran-Ferrer M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Stevenson KE; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, Spain., Barbera-Mourelle A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Taylor-Weiner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bousquets-Muñoz P; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain., Diaz-Navarro A; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain., Dunford A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Anand S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kretzmer H; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany., Gutierrez-Abril J; Computational Oncology Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., López-Tamargo S; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sun C; Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Sivina M; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Rassenti LZ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Schneider C; Department of Internal Medicine III, Ulm University, Ulm, Germany., Li S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Parida L; IBM Research, Yorktown Heights, NY, USA., Meissner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Aguet F; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Burger JA; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Wiestner A; Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Kipps TJ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Hallek M; Center for Molecular Medicine, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany., Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain., Puente XS; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Wu CJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cwu@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, USA. cwu@partners.org.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. cwu@partners.org., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Hematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.
Publikováno v:
Nature genetics [Nat Genet] 2022 Nov; Vol. 54 (11), pp. 1664-1674. Date of Electronic Publication: 2022 Aug 04.
Autor:
Kaufman M; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States., Yan XJ; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States., Li W; The Robert S. Boas Center for Genomics & Human Genetics, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States., Ghia EM; Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States., Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands., Rassenti LZ; Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States., Belessi C; Hematology Department, Nikea General Hospital, Pireaus, Greece., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Davi F; Department of Biological Hematology, Hôpital Pitié-Salpêtrière (AP-HP), Sorbonne Université, Paris, France., Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Pospisilova S; Department of Internal Medicine - Hematology and Oncology and Department of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Brown JR; Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Boston, MA, United States., Catherwood M; Clinical Hematology, Belfast City Hospital, Belfast, Ireland., Davis Z; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Oscier D; Department of Hematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Montillo M; Department of Hematology & Oncology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Trentin L; Hematology Unit, Department of Medicine-(DIMED), University of Padua University Hospital, Padua, Italy., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Ghia P; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Barrientos JC; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.; Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Departments of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Northwell Health Cancer Institute, Lake Success, NY, United States., Kolitz JE; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.; Northwell Health Cancer Institute, Lake Success, NY, United States., Allen SL; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.; Northwell Health Cancer Institute, Lake Success, NY, United States., Rai KR; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.; Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Departments of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Northwell Health Cancer Institute, Lake Success, NY, United States., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Kipps TJ; Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States., Chiorazzi N; Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.; Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Departments of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY, United States.; Northwell Health Cancer Institute, Lake Success, NY, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jul 12; Vol. 12, pp. 897280. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).
Autor:
Ghia EM; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA., Rassenti LZ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA., Choi MY; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.; CIRM Alpha Stem Cell Clinic at University of California, San Diego and Sanford Stem Cell Clinical Center, La Jolla, CA, 92037, USA., Quijada-Álamo M; University of Salamanca, IBSAL, IBMCC-CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Chu E; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA., Widhopf GF 2nd; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA., Kipps TJ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA. tkipps@health.ucsd.edu.; Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA, 92037, USA. tkipps@health.ucsd.edu.; Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA. tkipps@health.ucsd.edu.; CIRM Alpha Stem Cell Clinic at University of California, San Diego and Sanford Stem Cell Clinical Center, La Jolla, CA, 92037, USA. tkipps@health.ucsd.edu.
Publikováno v:
Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1609-1618. Date of Electronic Publication: 2022 Apr 13.
Autor:
Kluckova K; Centre for Haemato-Oncology, Barts Cancer Institute-A Cancer Research UK Centre of Excellence, Queen Mary University of London, United Kingdom., Clear AJ; Centre for Haemato-Oncology, Barts Cancer Institute-A Cancer Research UK Centre of Excellence, Queen Mary University of London, United Kingdom., D'Avola A; The Francis Crick Institute, London, United Kingdom., Rassenti LZ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Kipps TJ; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute-A Cancer Research UK Centre of Excellence, Queen Mary University of London, United Kingdom., Riches JC; Centre for Haemato-Oncology, Barts Cancer Institute-A Cancer Research UK Centre of Excellence, Queen Mary University of London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.
Publikováno v:
HemaSphere [Hemasphere] 2022 May 13; Vol. 6 (6), pp. e722. Date of Electronic Publication: 2022 May 13 (Print Publication: 2022).